Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the category archives: OBN News

Company announcement

Blue Earth Diagnostics continues to expand access to Axumin® (fluciclovine (18F)) in Europe

Oxford, UK – May 9, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced expanded access to Axumin® (fluciclovine (18F)) in Europe. The first commercial production of Axumin in Belgium occurred recently, with the first Belgian patients being dosed.

Read the rest of entry »

CHAIN Appoints New Non-Executive Directors

MARLOW & NOTTINGHAM, UK. -- April 8, 2019 – UK microbiome therapeutics company CHAIN Biotechnology has appointed two new non-executive directors, Dr Nel Moore and Dr Robert Haigh to the Board.

Read the rest of entry »

HemaCare and Tissue Solutions Announce Strategic Partnership to Expand Access to Human Disease-State Samples

(Los Angeles, CA and Glasgow U.K. – March 28, 2019) HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.

Read the rest of entry »

Arecor receives regulatory approval to initiate phase I clinical trial for ultra-rapid acting insulin product

Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that a Phase I Clinical Trial Application (“CTA”) for product candidate AT247 has been approved by the Bundesamt für Sicherheit im Gesundheitswesen (BASG), the Austrian Federal Office for Safety in Health Care.

Read the rest of entry »

New appointments strengthen the Aigenpulse Leadership team

Aigenpulse Ltd., (Aigenpulse), a big data technology company which specialises in structuring, integrating and deriving meaning from large, disparate data assets in the life sciences sector, is continuing to strengthen its management team with the addition of Head of Delivery and Head of DevOps.

Read the rest of entry »

PRESS RELEASE First production and administration of Axumin® (fluciclovine (18F)) in Italy.

Oxford, UK – February 12, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the first commercial production of Axumin® (fluciclovine (18F)) in Italy occurred recently, with the first Italian patients being dosed.

Read the rest of entry »

Super-Fast-Acting Prandial Insulin Product Receives £0.5M Innovate UK Boost

Arecor Ltd, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, is pleased to announce that the Company has been awarded a £0.5 million grant from Innovate UK, the UK’s innovation agency, to advance the Company's proprietary super-fast-acting prandial insulin product, AT270.

Read the rest of entry »

Grey Wolf Therapeutics completes £10 million ($14 million) series A financing.

Grey Wolf Therapeutics completes £10 million ($14 million) series A financing with Andera Partners and Canaan to fund development of immuno-oncology therapies to increase tumour visibility

Read the rest of entry »

Microbiological Considerations in Cleanroom Validation: Application Note Published in European Pharmaceutical Review

Wickham Laboratories Ltd is delighted to announce our most recent technical article on, “Microbiological Considerations in Cleanroom Validation”, which has been featured in European Pharmaceutical Review’s December 2018 issue.

Read the rest of entry »

Article on In Vitro Methods Published in IBI

Wickham Laboratories are excited to announce their most recent publication on “The Importance of Testing for Pyrogens in Raw and In-Process Materials”, written by Section Head of Endotoxin and Cytotoxicity Testing, Sophie Bell.

Read the rest of entry »

Pages: Previous1234567...19NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.